Cyclic Ion Mobility Resolves Biologically Relevant, Isomeric Endogenous Metabolites

Importance of the topic

Small molecule metabolites often occur as structural isomers whose differentiation is critical for accurate disease biomarker discovery and metabolic pathway elucidation. Conventional mass spectrometry may not distinguish isomers with nearly identical mass and collisional cross section values. High-resolution ion mobility, particularly cyclic ion mobility spectrometry (cIMS), offers an orthogonal separation based on ion travel time, enhancing specificity and identification confidence in metabolomic analyses.

Objectives and overview

This study aimed to evaluate the capacity of the SELECT SERIES Cyclic IMS platform to resolve biologically relevant isomeric endogenous metabolites. Two compound classes, methylhistidines and bile acids, were selected to demonstrate the application of multi-pass cIMS experiments in achieving baseline separation within millisecond timeframes.

Methodology and instrumentation

A standard mixture containing 1-methylhistidine, 3-methylhistidine, chenodeoxycholic acid and hyodeoxycholic acid was prepared in acetonitrile:water (1:1) for direct infusion at 10 µL/min. Negative electrospray ionization was employed with optimized source parameters. The Cyclic IMS instrument was operated in MS/MS mode, using the quadrupole to select the deprotonated molecular ions (m/z 168.07 for methylhistidines; m/z 391.28 for bile acids) and zero collision energy for mobility separation. Ions were cycled through the IMS cell multiple times to achieve enhanced resolution. Instrumentation used:

• SELECT SERIES Cyclic IMS
• Time-of-flight mass analyzer in V optics mode
• Electrospray ionization source
• Syringe pump for direct infusion

Main results and discussion

Multi-pass experiments revealed that 1- and 3-methylhistidine isomers reached baseline separation after five passes (<50 ms) with an IMS resolution of 145. Chenodeoxycholic and hyodeoxycholic acids were fully resolved after twenty passes (<200 ms) at a resolution of 290. Arrival times were confirmed by infusing individual standards and examining high-collision energy spectra to assign each peak to its corresponding isomer.

Benefits and practical applications

The multi-pass cIMS approach delivers rapid, high-resolution separation of isomeric metabolites without requiring additional chromatography systems or new LC method development. Key advantages include:

• Enhanced specificity through orthogonal ion mobility separation
• Cleaner MS/MS spectra leading to more reliable identification
• Fast analysis times compatible with high-throughput metabolomics
• Flexibility to incorporate into existing workflows

Future trends and opportunities

Emerging directions include integrating cyclic IMS with liquid chromatography for multidimensional separation, expanding CCS prediction databases for a broader range of metabolites, and applying machine learning models to optimize pass numbers and resolution settings. Clinical and pharmaceutical research may benefit from this technology for refined biomarker screening and mechanistic studies of isomer-specific metabolic pathways.

Conclusion

The SELECT SERIES Cyclic IMS platform demonstrated effective baseline separation of small polar isomeric metabolites within 200 ms using multi-pass ion mobility. This capability supports improved metabolite identification in complex biological samples without additional chromatographic methods, enhancing the power of metabolomic investigations.

Reference

1. Yamada T, Uchikata T, Sakamoto S, Yokoi Y, Nishiumi S, Yoshida M, et al. Supercritical Fluid Chromatography/Orbitrap Mass Spectrometry based Lipidomics Platform Coupled with Automated Lipid Identification Software for Accurate Lipid Profiling. J Chromatogr A. 2013;1301:237–42.
2. Sen A, Knappy C, Lewis MR, Plumb RS, Wilson ID, Nicholson JK, et al. Analysis of Polar Urinary Metabolites for Metabolic Phenotyping Using Supercritical Fluid Chromatography and Mass Spectrometry. J Chromatogr A. 2016;1449:141–55.
3. Giles K, Ujma J, Wildgoose J, Pringle S, Richardson K, Langridge D, et al. A Cyclic Ion Mobility-Mass Spectrometry System. Anal Chem. 2019;91(13):8564–73.
4. Fink K, Williams AD, Fink RM. 1-Methylhistidine Excretion by Vitamin E-deficient Rabbits. J Biol Chem. 1959;234(5):1182–5.
5. Chinkes DL. Methods for Measuring Tissue Protein Breakdown Rate In Vivo. Curr Opin Clin Nutr Metab Care. 2005;8:534–7.
6. Staels B, Fonseca VA. Bile Acids and Metabolic Regulation: Mechanisms and Clinical Responses to Bile Acid Sequestration. Diabetes Care. 2009;32 Suppl 2:S237–45.
7. Dawson PA, Karpen SJ. Intestinal Transport and Metabolism of Bile Acids. J Lipid Res. 2015;56(6):1085–99.
8. Matern H, Lappas N, SM. Isolation and Characterization of Hyodeoxycholic-acid UDP-Glucuronosyltransferase from Human Liver. Eur J Biochem. 1991;200:393–400.